Trial register facet
Phase 3 trial records — page 15
351 records at phase 3.
Showing 0 records on this page
Records
351 documents · page 15 of 15
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| GNRH-DIAGNOSTIC-REGIONAL-JPprogramme record | Gonadorelin | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-2-QOLprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-4-REGIONAL-JPprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SYNCHRONIZE-1-OLEprogramme record | Survodutide | Phase 3 | Ongoing | Single-arm open-label | — | — | Very low |
| DREAMS-3-REGIONAL-JPprogramme record | Mazdutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-2-BODY-COMPprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-3-BIOMARKERprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SYNCHRONIZE-1-ADHERENCEprogramme record | Survodutide | Phase 3 | Ongoing | Observational | — | — | Very low |
| DREAMS-3-REGIONAL-CNprogramme record | Mazdutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SEMAX-RU-COGNITIVE-REGIONAL-JPprogramme record | Semax | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-2-REGIONAL-JPprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SYNCHRONIZE-1-BIOMARKERprogramme record | Survodutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SYNCHRONIZE-2-REGIONAL-CNprogramme record | Survodutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| BPC-PH2-UC-REGIONAL-CNprogramme record | BPC-157 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| MARITIDE-PH3-BIOMARKERprogramme record | Maridebart cafraglutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
page 15 of 15